Kymab
Partnership targets immuno-oncology
Kymab and Heptares Therapeutics have entered a strategic collaboration to discover, develop and commercialise novel antibody therapeutics targeting a number of G protein-coupled receptors (GPCR) with an initial focus on immuno-oncology. Read more
Top 5 collaborations tackling cancer
Pharma companies have been teaming up in the fight against cancer. EPM lists the top 5 cancer fighting collaborations Read more
MD Anderson and Kymab team up for cancer drug development
Kymab and MD Anderson Cancer Centre have announced a strategic cancer drug discovery and development alliance Read more
Biotech Kymab is Sunday Times' 'one to watch’
Kymab, a Cambridge-based antibodies-to-medicines company, is featured in the top ten of The Sunday Times Tech Track ‘Ones to Watch’ 2015 list Read more
Kymab and the Wellcome Trust initiate Ebola Project
Team effort: Drug discovery partnership to produce an antibody-based medicine to fight Ebola infection Read more
